|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Jones RJ, Matsui WH and Smith BD: Cancer
stem cells: Are we missing the target? J Natl Cancer Inst.
96:583–585. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ and Hart IR: Biological
diversity in metastatic neoplasms: Origins and implications.
Science. 217:998–1003. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heppner GH and Miller BE: Tumor
heterogeneity: Biological implications and therapeutic
consequences. Cancer Metastasis Rev. 2:5–23. 1983. View Article : Google Scholar
|
|
5
|
Nowell PC: Mechanisms of tumor
progression. Cancer Res. 46:2203–2207. 1986.PubMed/NCBI
|
|
6
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greaves M: Cancer stem cells as ‘units of
selection’. Evol Appl. 6:102–108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Y, Dallaglio K, Chen Y, Robinson WA,
Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris
DA, et al: ALDH1A isozymes are markers of human melanoma stem cells
and potential therapeutic targets. Stem Cells. 30:2100–2113. 2012.
View Article : Google Scholar :
|
|
11
|
Landen CN Jr, Goodman B, Katre AA, Steg
AD, Nick AM, Stone RL, Miller LD, Mejia PV, Jennings NB, Gershenson
DM, et al: Targeting aldehyde dehydrogenase cancer stem cells in
ovarian cancer. Mol Cancer Ther. 9:3186–3199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rahadiani N, Ikeda J, Mamat S, Matsuzaki
S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, et al:
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid
adenocarcinoma and its clinical implications. Cancer Sci.
102:903–908. 2011. View Article : Google Scholar
|
|
13
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim MP, Fleming JB, Wang H, Abbruzzese JL,
Choi W, Kopetz S, McConkey DJ, Evans DB and Gallick GE: ALDH
activity selectively defines an enhanced tumor-initiating cell
population relative to CD133 expression in human pancreatic
adenocarcinoma. PLoS One. 6:e206362011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sullivan JP, Spinola M, Dodge M, Raso MG,
Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et
al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin J, Liu X, Laffin B, Chen X, Choy G,
Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, et al: The
PSA(−/lo) prostate cancer cell population harbors self-renewing
long-term tumor-propagating cells that resist castration. Cell Stem
Cell. 10:556–569. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van den Hoogen C, van der Horst G, Cheung
H, Buijs JT, Lippitt JM, Guzmán-Ramírez N, Hamdy FC, Eaton CL,
Thalmann GN, Cecchini MG, et al: High aldehyde dehydrogenase
activity identifies tumor-initiating and metastasis-initiating
cells in human prostate cancer. Cancer Res. 70:5163–5173. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu
Z, Stass SA and Jiang F: Aldehyde dehydrogenase 1 A1-positive cell
population is enriched in tumor-initiating cells and associated
with progression of bladder cancer. Cancer Epidemiol Biomarkers
Prev. 19:327–337. 2010. View Article : Google Scholar
|
|
19
|
Chu P, Clanton DJ, Snipas TS, Lee J,
Mitchell E, Nguyen ML, Hare E and Peach RJ: Characterization of a
subpopulation of colon cancer cells with stem cell-like properties.
Int J Cancer. 124:1312–1321. 2009. View Article : Google Scholar
|
|
20
|
Carpentino JE, Hynes MJ, Appelman HD,
Zheng T, Steindler DA, Scott EW and Huang EH: Aldehyde
dehydrogenase-expressing colon stem cells contribute to
tumorigenesis in the transition from colitis to cancer. Cancer Res.
69:8208–8215. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
23
|
Vasiliou V and Nebert DW: Analysis and
update of the human aldehyde dehydrogenase (ALDH) gene family. Hum
Genomics. 2:138–143. 2005.PubMed/NCBI
|
|
24
|
Marchitti SA, Brocker C, Stagos D and
Vasiliou V: Non-P450 aldehyde oxidizing enzymes: The aldehyde
dehydrogenase superfamily. Expert Opin Drug Metab Toxicol.
4:697–720. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Orlicky DJ, Matsumoto A, Singh S,
Thompson DC and Vasiliou V: Aldehyde dehydrogenase 1B1 (ALDH1B1) is
a potential biomarker for human colon cancer. Biochem Biophys Res
Commun. 405:173–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marcato P, Dean CA, Pan D, Araslanova R,
Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, et al:
Aldehyde dehydrogenase activity of breast cancer stem cells is
primarily due to isoform ALDH1A3 and its expression is predictive
of metastasis. Stem Cells. 29:32–45. 2011. View Article : Google Scholar
|
|
27
|
Vasiliou V, Thompson DC, Smith C, Fujita M
and Chen Y: Aldehyde dehydrogenases: From eye crystallins to
metabolic disease and cancer stem cells. Chem Biol Interact.
202:2–10. 2013. View Article : Google Scholar
|
|
28
|
Levi BP, Yilmaz OH, Duester G and Morrison
SJ: Aldehyde dehydrogenase 1a1 is dispensable for stem cell
function in the mouse hematopoietic and nervous systems. Blood.
113:1670–1680. 2009. View Article : Google Scholar :
|
|
29
|
Rovira M, Scott SG, Liss AS, Jensen J,
Thayer SP and Leach SD: Isolation and characterization of
centroacinar/terminal ductal progenitor cells in adult mouse
pancreas. Proc Natl Acad Sci USA. 107:75–80. 2010. View Article : Google Scholar :
|
|
30
|
Marchitti SA, Orlicky DJ, Brocker C and
Vasiliou V: Aldehyde dehydrogenase 3B1 (ALDH3B1):
Immunohistochemical tissue distribution and cellular-specific
localization in normal and cancerous human tissues. J Histochem
Cytochem. 58:765–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishikawa S, Konno M, Hamabe A, Hasegawa
S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, et al:
Aldehyde dehydrogenase high gastric cancer stem cells are resistant
to chemotherapy. Int J Oncol. 42:1437–1442. 2013.PubMed/NCBI
|
|
32
|
Katsuno Y, Ehata S, Yashiro M, Yanagihara
K, Hirakawa K and Miyazono K: Coordinated expression of REG4 and
aldehyde dehydrogenase 1 regulating tumourigenic capacity of
diffuse-type gastric carcinoma-initiating cells is inhibited by
TGF-β. J Pathol. 228:391–404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y,
Uraoka N, Anami K, Sentani K, Oue N and Yasui W: Expression of
cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and
lymph node metastasis of gastric cancer. Pathol Int. 62:112–119.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: Its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Storms RW, Trujillo AP, Springer JB, Shah
L, Colvin OM, Ludeman SM and Smith C: Isolation of primitive human
hematopoietic progenitors on the basis of aldehyde dehydrogenase
activity. Proc Natl Acad Sci USA. 96:9118–9123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kastan MB, Schlaffer E, Russo JE, Colvin
OM, Civin CI and Hilton J: Direct demonstration of elevated
aldehyde dehydrogenase in human hematopoietic progenitor cells.
Blood. 75:1947–1950. 1990.PubMed/NCBI
|
|
37
|
Collins SJ: Retinoic acid receptors,
hematopoiesis and leukemogenesis. Curr Opin Hematol. 15:346–351.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu SY and Zheng PS: High aldehyde
dehydrogenase activity identifies cancer stem cells in human
cervical cancer. Oncotarget. 4:2462–2475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Charafe-Jauffret E, Ginestier C, Iovino F,
Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci
F, Jacquemier J, et al: Aldehyde dehydrogenase 1-positive cancer
stem cells mediate metastasis and poor clinical outcome in
inflammatory breast cancer. Clin Cancer Res. 16:45–55. 2010.
View Article : Google Scholar
|
|
42
|
Deng S, Yang X, Lassus H, Liang S, Kaur S,
Ye Q, Li C, Wang LP, Roby KF, Orsulic S, et al: Distinct expression
levels and patterns of stem cell marker, aldehyde dehydrogenase
isoform 1 (ALDH1), in human epithelial cancers. PLoS One.
5:e102772010. View Article : Google Scholar :
|
|
43
|
Yang L, Ren Y, Yu X, Qian F, Bian BS, Xiao
HL, Wang WG, Xu SL, Yang J, Cui W, et al: ALDH1A1 defines invasive
cancer stem-like cells and predicts poor prognosis in patients with
esophageal squamous cell carcinoma. Mod Pathol. 27:775–783. 2014.
View Article : Google Scholar
|
|
44
|
Zhou W, Lv R, Qi W, Wu D, Xu Y, Liu W, Mou
Y and Wang L: Snail contributes to the maintenance of stem
cell-like phenotype cells in human pancreatic cancer. PLoS One.
9:e874092014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
van den Hoogen C, van der Horst G, Cheung
H, Buijs JT, Pelger RC and van der Pluijm G: The aldehyde
dehydrogenase enzyme 7A1 is functionally involved in prostate
cancer bone metastasis. Clin Exp Metastasis. 28:615–625. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yan J, De Melo J, Cutz JC, Aziz T and Tang
D: Aldehyde dehydrogenase 3A1 associates with prostate
tumorigenesis. Br J Cancer. 110:2593–2603. 2014. View Article : Google Scholar :
|
|
47
|
Singh S, Brocker C, Koppaka V, Chen Y,
Jackson BC, Matsumoto A, Thompson DC and Vasiliou V: Aldehyde
dehydrogenases in cellular responses to oxidative/electrophilic
stress. Free Radic Biol Med. 56:89–101. 2013. View Article : Google Scholar :
|
|
48
|
Gasparetto M, Sekulovic S, Brocker C, Tang
P, Zakaryan A, Xiang P, Kuchenbauer F, Wen M, Kasaian K, Witty MF,
et al: Aldehyde dehydrogenases are regulators of hematopoietic stem
cell numbers and B-cell development. Exp Hematol. 40:318–329.e2.
2012. View Article : Google Scholar
|
|
49
|
Moreb JS, Mohuczy D, Ostmark B and Zucali
JR: RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and
class-3A1 is specific and reveals that each contributes equally to
the resistance against 4-hydroperoxycyclophosphamide. Cancer
Chemother Pharmacol. 59:127–136. 2007. View Article : Google Scholar
|
|
50
|
Muzio G, Trombetta A, Maggiora M,
Martinasso G, Vasiliou V, Lassen N and Canuto RA: Arachidonic acid
suppresses growth of human lung tumor A549 cells through
down-regulation of ALDH3A1 expression. Free Radic Biol Med.
40:1929–1938. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pappa A, Brown D, Koutalos Y, DeGregori J,
White C and Vasiliou V: Human aldehyde dehydrogenase 3A1 inhibits
proliferation and promotes survival of human corneal epithelial
cells. J Biol Chem. 280:27998–28006. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Muzio G, Trombetta A, Martinasso G, Canuto
RA and Maggiora M: Antisense oligonucleotides against aldehyde
dehydrogenase 3 inhibit hepatoma cell proliferation by affecting
MAP kinases. Chem Biol Interact. 143–144:37–43. 2003. View Article : Google Scholar
|
|
53
|
Wang JS, Fang Q, Sun DJ, Chen J, Zhou XL,
Lin GW, Lu HZ and Fei J: Genetic modification of hematopoietic
progenitor cells for combined resistance to
4-hydroperoxycyclophosphamide, vincristine, and daunorubicin. Acta
Pharmacol Sin. 22:949–955. 2001.PubMed/NCBI
|
|
54
|
Canuto RA, Muzio G, Ferro M, Maggiora M,
Federa R, Bassi AM, Lindahl R and Dianzani MU: Inhibition of
class-3 aldehyde dehydrogenase and cell growth by restored lipid
peroxidation in hepatoma cell lines. Free Radic Biol Med.
26:333–340. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Calderaro J, Nault JC, Bioulac-Sage P,
Laurent A, Blanc JF, Decaens T and Zucman-Rossi J: ALDH3A1 is
overexpressed in a subset of hepatocellular carcinoma characterised
by activation of the Wnt/β-catenin pathway. Virchows Arch.
464:53–60. 2014. View Article : Google Scholar
|
|
56
|
Vesuna F, Lisok A, Kimble B and Raman V:
Twist modulates breast cancer stem cells by transcriptional
regulation of CD24 expression. Neoplasia. 11:1318–1328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
